Jeffrey Liebmann
MD | Glaucoma Specialist | 43+ years Exp
Medicare Enrolled 635 W 165th St, New York
New York, 10032-3724
212-305-9535 212-305-5523
Maps & DirectionsJeffrey Liebmann is a New York, New York based Glaucoma Specialist with 43 years of experience in Glaucoma Specialist. He completed his graduation from Boston University School Of Medicine in 1983. He is also affiliated with hospitals like New York-presbyterian Hospital and Ny Eye And Ear Infirmary Of Mount Sinai. He accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Jeffrey Liebmann is 161412 for Ophthalmology in New York.
Jeffrey Liebmann specializes in the treatment of glaucoma and other disorders related to increased intraocular pressure and optic nerve damage. This specialty involves the medical and surgical treatment of these conditions. Glaucoma specialists are trained to diagnose and manage glaucoma, including the use of medications, laser therapy, and surgical interventions to lower intraocular pressure and prevent vision loss.
Complete Profile:
Jeffrey Liebmann speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
| Specialization: | Glaucoma Specialist |
| Credentials: | MD |
| Experience: | 43+ years |
| Medical School Attended: | Boston University School Of Medicine |
| Graduation Year: | 1983 |
| Gender: | Male |
| Accepts Medicare Assignment: | Yes |
| Practice Address: | 635 W 165th St, New York,
New York, 10032-3724 |
| Phone: | 212-305-9535 |
| Fax: | 212-305-5523 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
| PAC ID: | 4385628437 |
| Enrollment ID: | I20040616000228 |
| NPI Number: | 1033199450 |
| NPI Enumeration Date: | 20 Jan, 2006 |
| NPI Last Update On: | 19 Feb, 2018 |
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Jeffrey Liebmann are as mentioned below.
| License Number | Specialization | State | Status | |
| 161412 | Ophthalmology | New York | Primary | |
| 161412 | Glaucoma Specialist | New York | Secondary | |
Hospital Affiliation:
Doctors can be affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
| Hospital Name (CCN) | State | Hospital Type |
| New York-presbyterian Hospital (330101) | New york, NY | Acute Care Hospital |
| Ny Eye And Ear Infirmary Of Mount Sinai (330100) | New york, NY | Acute Care Hospital |
Group Practice:
Group practices are run by a group of physicians who share their premises and other resources. Following list states all the group name
with which Jeffrey Liebmann has association with along with the number of members in that group.
| Organization Name (Group PAC ID) | Members |
| Trustees Of Columbia University In The City Of New York (8527972546) | 1693 |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 635 W 165th Street, Harkness Eye Institute
New York, New York |
| Zip: | 10032 |
| Phone Number: | 212-305-6709 |
| Fax Number: | 212-305-5523 |
Patients can reach Jeffrey Liebmann at
635 W 165th St, New York, New York or can
call to book an appointment on 212-305-9535.
Comments/ Reviews:
Patients can read all the reviews posted for Jeffrey Liebmann below. You may also share your own experience like the quality of treatment, behavior, and overall care provided by Jeffrey Liebmann. It will help others make informed decisions.
** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 July, 2026.